Congress Materials

Medical Information
Gulf Countries
 

This medical information website is intended only for healthcare professionals in the following Gulf Countries (UAE, Oman, Bahrain, Qatar and Kuwait). This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
SelectI am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
I am a patient / caregiverNo, go back to the patient portal
SelectI am a patient / caregiverNo, go back to the patient portal
I am a Healthcare Professional in another country.
The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Kristian Reich, Fernando Valenzuela, H. Chih-ho Hong, Zakiya P. Rice, Fan Zhang, Marco DiBonaventura, Urs Kerkmann, Tamara A. Bratt, Ricardo Rojo, Claire Clibborn June 13, 2021 RAD - June 2021 Atopic Dermatitis

A Phase 3 Double-Blind, Double-Dummy, Active-Controlled, Study to Evaluate the Efficacy and Safety of Abrocitinib Compared to Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis Receiving Background Topical Therapy (JADE DARE)

View Presentation
Poster
Emma Guttman-Yassky, Robert Bissonnette, Seth Forman, Karen Page, Ricardo Rojo, Hedieh Saffari, Svitlana Y. Tatulych, David Williams, April ArmstrongY June 13, 2021 RAD - June 2021 Atopic Dermatitis

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 2a Study to Evaluate the Mechanism of Action of Abrocitinib Monotherapy for Moderate-to-Severe Atopic Dermatitis (JADE MOA)

View Presentation
Poster
Vivian Shi, Tina Bhutani, Mette Deleuran, Luz Fonacier, Stephen Shumack, Fan Zhang, Michael Cameron, Gary Chan, Hernan Valdez, Natalie Yin June 13, 2021 RAD - June 2021 Atopic Dermatitis

Abrocitinib in the Treatment of Moderate-to-Severe Atopic Dermatitis Refractory to Dupilumab Treatment: An Analysis of JADE-EXTEND, a Phase 3 Long-Term Extension Study

View Presentation
Poster
Peter Lio, Mark Boguniewicz, Andrew Alexis, Mark Lebwohl, Kristian Reich, Andrew Pink, Kenji Kabashima, Robert Bissonnette, Roman J. Nowicki, Hernan Valdez, Fan Zhang, Marco DiBonaventura, Claire Clibborn, Michael C. Cameron June 13, 2021 RAD - June 2021 Atopic Dermatitis

Depth and Rapidity of Response With Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in JADE COMPARE

View Presentation
Poster
Eric Simpson, Peter Lio, Candrice Heath, Mark Boguniewicz, Mark Levenberg, Pinaki Biswas, Saleem Farooqui, Urs Kerkmann June 13, 2021 RAD - June 2021 Atopic Dermatitis

Efficacy and Safety of Abrocitinib in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis: Stratified Analysis Across 3 Clinical Trials

View Presentation
Poster
Lawrence F. Eichenfield, Carsten Flohr, Christine Bangert, Alan D. Irvine, Stephan Weidinger, John Nesnas, Herwig Koppensteiner, Fan Zhang, Ricardo Rojo, Gary Chan June 13, 2021 RAD - June 2021 Atopic Dermatitis

Efficacy and Safety of Abrocitinib in Adolescents With Moderate-To-Severe Atopic Dermatitis From the JADE Clinical Trial Program

View Presentation
Poster
Andrew F. Alexis, Jonathan I. Silverberg, Zakiya P. Rice, April W. Armstrong, Seemal R. Desai, Luz Fonacier, Kenji Kabashima, Mark Levenberg, Pinaki Biswas, Ricardo Rojo Cella, Gary L. Chan June 13, 2021 RAD - June 2021 Atopic Dermatitis

Efficacy of Abrocitinib Monotherapy for the Treatment of Moderate-to-Severe Atopic Dermatitis by Race

View Presentation
Oral Presentation
Andrew F. Alexis, Jonathan I. Silverberg, Zakiya P. Rice, April W. Armstrong, Seemal R. Desai, Luz Fonacier, Kenji Kabashima, Mark Levenberg, Pinaki Biswas, Ricardo Rojo Cella, Gary L. Chan June 13, 2021 RAD - June 2021 Atopic Dermatitis

Efficacy of Abrocitinib Monotherapy for the Treatment of Moderate-to-Severe Atopic Dermatitis by Race

View Presentation
Poster
Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Min Zhang, Saleem A. Farooqui, Susan Johnson, Andrew Thorpe, Ricardo Rojo June 13, 2021 RAD - June 2021 Atopic Dermatitis

Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis (AD) From the Phase 2 and Phase 3 Clinical Trial Program

View Presentation
Poster
Melinda Gooderham, Gil Yosipovitch, Sonja Staender, Luz Fonacier, Jacek Szepietowski, Mette Deleuran, Giampiero Girolomoni, Andrew Bushmakin, Joseph Cappelleri, Melissa Watkins, Claire Feeney, Hernan Valdez, Ricardo Rojo, Marco DiBonaventura, Daniela Myers June 13, 2021 RAD - June 2021 Atopic Dermatitis

Interpreting the Relationship Between Pruritus and Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-1 and MONO-2

View Presentation